Questions discussed in this category
Will you recommend this as a first-line agent? Will you use this as monotherapy or only in combination with other agents like duloxetine?
Will you try the sublingual formulation in a patient who has failed the oral formulation, or vice versa?
What tools do you track to assess progress toward these goals?
Would you consider charging a small fee for managing C-2 prescriptions between appointments instead of requiring the patient to come monthly?
271031936027092249042711627252270932616721672
Papers discussed in this category
Frontiers in medicine, 2023 Apr 25
Arthritis and rheumatism, 1994-01
Pain medicine (Malden, Mass.), 2025 Jul 08
Arthritis care & research, 2023 Jul 04
Annals of medicine, 2011 Jul 19